Spending like a bigger company on purpose: current results carry the cost of an expansion aimed at demand management say
The model's full reasoning — Q3 2022 call → NOWe need to determine if management acknowledges that current results are being weighed down by an expansion already undertaken, and justifies it with demand already real. First, look for expansion: hiring, capacity, etc. In the call, Gleb mentions investments in B2, partnerships, developer evangelism, etc. Frank mentions "planned expenses from higher investments in both sales and marketing and R&D" and "increased G&A expenses chiefly related to public company cost." Also, they mention "we continue to increase investments to pursue the large market potential for B2 Cloud Storage." They also mention "we are calibrating our spend" and "we have accelerated some of those investments and we've moderated others." They talk about "we stood up a lot of programs simultaneously" and "we're monitoring them all." They also mention "we are actively going through a process that is evaluating, what investments do we want to accelerate, what investments do we want to decelerate." So they acknowledge they are investing heavily, and that this is affecting EBITDA (negative EBITDA). They say "adjusted EBITDA was a loss of $1.9 million" and they attribute it to "planned expenses from higher investments." So they acknowledge the cost. Now, do they justify it with demand already real? They mention "B2 Cloud Storage business grew 48%", "developers with paid data storage up over 80% year-on-year", "B2 Reserve show a nice initial ramp in demand with revenue increasing each month of Q3", "we are pleased to see B2 Reserve show a nice initial ramp in demand", "we continue to see that as an important consideration" etc. They also mention "we are excited about those opportunities" and "we are seeing" some things. But is the demand "already real" as in orders, commitments, etc.? They mention "B2 Reserve contracts are effectively committed contracts." They also mention "we are actively pursuing larger contracts" but that's future. They mention "we are seeing" some benefits but also "we're not for example seeing as much benefit to-date, as we expected from our growth initiatives." That suggests they are not seeing as much demand as hoped. They also say "we believe the top line revenue forecast of approximately $100 million for 2023 is appropriate" and they are adjusting expenses. So they are not justifying the expansion with strong current demand; they are actually tempering expectations.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| PTLO | Portillo's Inc. | Q2 2023 | 2023-08-05 | B |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| KE | Kimball Electronics, Inc. | Q3 2023 | 2023-05-06 | C+ |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| CHE | Chemed Corporation | Q3 2022 | 2022-11-01 | B+ |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| HLIO | Helios Technologies, Inc. | Q1 2022 | 2022-05-10 | C |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| LMAT | LeMaitre Vascular, Inc. | Q3 2021 | 2021-10-29 | C+ |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| JBT | John Bean Technologies Corporation | Q2 2018 | 2018-07-26 | B |
| CP | Canadian Pacific Railway Limited | Q2 2018 | 2018-07-19 | B+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| IR | Ingersoll-Rand Plc | Q3 2017 | 2017-10-25 | B |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
SIBN · Q3 2022 → YESThe question is: Does management acknowledge that the company's CURRENT reported results are being visibly weighed down by the cost of an expansion the company has ALREADY undertaken — spending, hirin...YES Management explicitly describes the expansion as already underway and costing the company now: investments in sales force (85 territory managers + 72 specialists), new products (iFuse-TORQ, iFuse-Bedrock Granite), instrument trays, inventory, and R&D that are driving higher depreciation, freight, and product costs 84% gross margin (down low-single digits from these factors). Anshul confirms “we’ve made a substantial amount of investment whether it’s in TORQ trays or Granite trays or TORQ implants” and “this is going to lead to elevated depreciation,” while Laura notes the build supports “strong new product demand.
FLYW · Q1 2022 → YESThe question is: Does management acknowledge that the company's CURRENT reported results are being visibly weighed down by the cost of an expansion the company has ALREADY undertaken, AND justify carr...YES The transcript shows management explicitly linking the current EBITDA decline to the hiring expansion already completed ("increased the number of FlyMates by over 50% during the past year" and "added over 100 new FlyMates within the sales, marketing and product functions"), while framing the spending as a deliberate, ongoing 2022 investment plan that is already delivering observable results through record client adds (130), pipeline growth, and strong ARR signings.
EVGO · Q2 2022 → YESThe question is: Does management acknowledge that the company's CURRENT reported results are being visibly weighed down by the cost of an expansion the company has ALREADY undertaken, AND justify carr...YES Management describes concrete expansion already underway—170 stalls placed in Q2, total stalls at 2,397 with 460 under construction, pipeline at 3,669, CapEx jumped to $44 million to accelerate deployment, and G&A ramping personnel to support growth—while directly tying the resulting negative adjusted EBITDA of -$19.8 million to that deliberate build-out.